Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × Midazolam × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 3 Neoplasms 2 Melanoma 2 Advanced Malignancies 2 Urothelial Cancer 1 Thyroid Neoplasms 1 Solid Tumors, KRAS Mutation 1 Sarcoma, Synovial 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Opioid-Related Disorders 1 Lung Neoplasms 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia 1 Leiomyosarcoma 1 KRAS p.G12C Mutant Advanced Solid Tumors 1 Hematologic Neoplasms 1 Healthy Adult Participants 1 Glioma 1 Colorectal Neoplasms 1 Choledocholithiasis 1 Choledochal Cyst 1 Cholangitis 1 Central Nervous System Neoplasms 1

Interventions

Dexamethasone 16 Lenalidomide 12 Bortezomib 9 Cyclophosphamide 7 carfilzomib 6 Whole-Body Irradiation 6 Melphalan 6 fludarabine 5 daratumumab 5 Tacrolimus 5 Mycophenolic Acid 5 Calcium Dobesilate 5 pomalidomide 3 fludarabine phosphate 3 belantamab mafodotin 3 Radiotherapy 3 gamma-Globulins 2 elotuzumab 2 Trimethoprim, Sulfamethoxazole Drug Combination 2 Sirolimus 2 Prednisone 2 Immunoglobulins, Intravenous 2 Hematopoietic Stem Cell Transplantation 2 Etoposide 2 venetoclax 1 thymoglobulin 1 siltuximab 1 poly ICLC 1 pembrolizumab 1 ixazomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡